KONTROLLIERTE FREISETZUNG 25-HYDROXYVITAMIN D
European patent · EP3342405 · In force
Register entry
- Publication number
- EP3342405
- Application number
- EP18154616
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 25, 2008
- Published
- Jul 4, 2018
- Granted
- Aug 21, 2019
- Protection ends at the latest
- Apr 24, 2028
- Next annual fee due
- Apr 30, 2027
- IPC classes
- A61K 9/48 (2006.01)A61K 31/593 (2006.01)A61K 47/06 (2006.01)A61K 47/14 (2017.01)A61K 47/44 (2017.01)
- Priority
- US 913853 P 25.04.2007
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 1, 2026
Change
Published in Swissreg on 01.05.2026
- May 1, 2025
Change
Published in Swissreg on 01.05.2025
- May 1, 2024
Change
Published in Swissreg on 01.05.2024
- May 1, 2023
Change
Published in Swissreg on 01.05.2023
- Aug 31, 2021
Transferred
- Owner
- Opko Ireland Global Holdings, Ltd., Citywest Business Campus, 3013 Lake Drive, Dublin 24, Ireland, Opko Renal, LLC, 4400 Biscayne Boulevard, Miami, FL 33137, USA → EirGen Pharma Ltd., Westside Business Park, Old Kilmeaden Road, Waterford X91 YV67, Ireland, Opko Renal, LLC, 4400 Biscayne Boulevard, Miami, FL 33137, USA
Published in Swissreg on 31.08.2021
- Aug 21, 2019
Granted
Published in Swissreg on 21.08.2019
Parties
Holder
Inventor
Mississauga, Ontario L5M 0C5, CA
Lake Forest, IL Illinois 60045, US
Miami, FL Florida 33141, US
Newmarket, Ontario L3X 1T3, CA
Kingston, Ontario K7M 4E8, CA
Whitby, Ontario L1R 2Z9, CA
Denver, CO Colorado 80202, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.